The largest database of trusted experimental protocols

4 protocols using endostatin

1

Metabolic and Inflammatory Biomarkers Assessment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples were drawn after an overnight fast (12 hours). Blood pressure was measured by an automatic upper arm monitor (Omron M6; OMRON Healthcare Europe, Hoofddorp, the Netherlands). Blood lipids, glucose, insulin, and C‐reactive protein were measured by standard laboratory methods at Uppsala University Hospital. Homeostasis model assessment of insulin resistance was calculated as glucose×insulin/22.5. ELISA was used to determine proinsulin (Mercodia, Uppsala, Sweden), PCSK9 (CycLex, Nagano, Japan), FGF21, IL‐6, IL‐8, IL‐15, IL‐1 receptor antagonist, TNFα, vascular cell adhesion molecule‐1, intercellular adhesion molecule‐1, E‐selectin, endostatin, and TNF receptor 2 (R&D Systems, Minneapolis, MN). Serum unesterified lathosterol was determined by isotope dilution mass spectrometry and corrected for total cholesterol.7 (link) Total NEFA were analyzed using the NEFA FS response kit (Cat. No. 157819910921; DiaSys Diagnostic Systems, Holzheim, Germany), an enzymatic end point method automatically measured on Response 910 (DiaSys Diagnostic Systems) according to the manufacturer's instructions. Von Willebrand factor was measured by ELISA with antisera from Dako (Glostrup, Denmark). The assay was calibrated against Liatest (DiagnosticaStago, Asnieres, France).
+ Open protocol
+ Expand
2

Evaluating Riociguat's Impact on Cardiovascular Biomarkers

Check if the same lab product or an alternative is used in the 5 most similar protocols
To examine the effect of riociguat on biomarkers, patient plasma was collected at baseline and week 16. Plasma from age- and sex-matched healthy controls was also obtained. The biomarkers were measured by enzyme-linked immunosorbent assays (ELISA) and included total vascular endothelial growth factor (VEGF, R&D Systems), tissue plasminogen activator (tPA, Abcam), soluble E-selectin (sE-selectin, R&D Systems), basic fibroblast growth factor (bFGF, R&D Systems), vascular cell adhesion molecule 1 (VCAM-1, RayBiotech), soluble intracellular adhesion molecule 1 (sICAM-1, RayBiotech), N-terminal propeptide of type I collagen (PINP, MyBioSource), matrix metalloproteinase 12 (MMP12, RayBiotech), CXCL4 (R&D Systems), cyclic guanylyl cyclase (cGMP, Cayman Chemical), endostatin (R&D Systems), and soluble fms-like tyrosine kinase 1 (sFLT1, R&D Systems).
+ Open protocol
+ Expand
3

Endostatin-Loaded Hydrogel Scaffold Fabrication

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hydrogel scaffolds (HS) were prepared as published by Deponti et al. [43 (link)] with some modifications. Briefly, after being trypsinized (0.05% trypsin EDTA, EuroClone, Pavia, Italy) at P3, the cells (80 × 106 cells/mL) were re-suspended in a solution named A containing fibrinogen bovine plasma (113.2 mg/mL, Aigma-Aldrich, St. Louis, MA, USA), aprotinin (3.24 mg/mL, Sigma-Aldrich, St. Louis, MA, USA), tranexamic acid (30 mg/mL, Sigma-Aldrich, St. Louis, MA, USA) in PBS. The scaffolds were assembled in a 96-well plate: first, 150 µL of solution A was placed in a well, secondly, 150 µL of solution B (thrombin, 13.7 mg/mL in PBS, Millipore, Temecula, CA, USA) was added. The scaffolds polymerized after 30 min under a sterile hood at room temperature, and then they were removed from wells and immersed for 9 days or for 21 days in different concentrations of exogenous endostatin (R&D System, MN, USA) dissolved in culture medium: (i) 10 ng/mL (E10), (ii) 100 ng/mL (E100), (iii) 200 ng/mL (E200), (iv) no endostatin added as negative control (UNT). Four replicates for each treatment and time points were maintained in vitro, changing culture medium twice a week. At the end of each time point, samples were stored at −80 °C for biochemical and molecular analyses or fixed in 4% buffered formalin (Bio-Optica, Milan, Italy) for morphological analysis.
+ Open protocol
+ Expand
4

Age-related Changes in Circulating Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The peripheral blood samples were obtained from younger (18 -64 years old) and older (≥ 65 years old) healthy volunteers recruited for The Dunhill Medical Trust EPC study (DMT EPC study, NCT02980354). elsewhere (Rakkar et al. 2020) (link).
The quantities of nonhaematopoietic cells (CD45-) expressing markers for stemness (CD34), immaturity (CD133) and/or endothelial maturity (KDR) were detected in peripheral blood by flow cytometry in that fluorescein isothiocyanate (BD Biosciences, Franklin Lakes, NJ, USA), phycoeryhtrin-cyanine7-(BD Biosciences), allophycocyanin-(Miltenyi Biotech), and phycoeryhtrin-(R&D Systems) labelled antibodies were used. The changes in plasma total anti-oxidant capacity (Abcam) as well as TNF- (R&D Systems), SDF-1 (R&D Systems), G-CSF (R&D Systems), VEGF (R&D Systems), PDGF-BB (R&D Systems), endostatin (R&D Systems), angiostatin (Abcam), thrombospondin-1 (R&D Systems), and thrombospondin-2 (R&D Systems) levels were assessed using the specific ELISA kits as per the manufacturers' instructions.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!